Barkha V Amlani, MD
Rheumatology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 23
- 5 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
23 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Amlani’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
23 of 23 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$12,882
Medicare paid this office $12,882 for 86 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 74 | $8,955 | $74 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 15 | $1,240 | $59 |
Who their Medicare patients are
86 Original Medicare patients in 2024. Average age 71 · Women 73% · Also on Medicaid 80% · Health risk score 1.71. Above the middle of the specialty; the typical rheumatology clinician is at 1.38.
Conditions among them: High blood pressure 73% · Diabetes 30% · Chronic kidney disease 28% · Heart failure 22% · Atrial fibrillation 20% · Coronary heart disease 16% · Depression 16% · COPD 13%.
The office billed $128,862, Medicare allowed $18,776 and paid $12,882; for 175 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 86 | 175 | 71 | 1.71 | $128,862 | $12,882 |
| 2023 | 95 | 169 | 72 | 1.62 | $123,266 | $13,126 |
| 2022 | 132 | 230 | 71 | 1.47 | $145,853 | $13,655 |
| 2021 | 151 | 257 | 70 | 1.47 | $153,219 | $18,056 |
| 2020 | 177 | 389 | 70 | 1.85 | $218,227 | $19,817 |
| 2019 | 218 | 564 | 69 | 1.60 | $367,582 | $34,641 |
| 2018 | 103 | 240 | 67 | 1.60 | $70,024 | $10,899 |
| 2017 | 20 | 34 | 69 | 1.17 | $10,199 | $2,466 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Return visit (30+ min) | 83 | $9,850 | $75 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 12 | $1,032 | $69 |
2022: 3 services
| Return visit (30+ min) | 102 | $9,625 | $65 |
| Short return visit (20+ min) | 21 | $1,203 | $55 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 12 | $842 | $50 |
2021: 4 services
| Return visit (30+ min) | 110 | $11,265 | $85 |
| Short return visit (20+ min) | 41 | $2,402 | $55 |
| Telephone medical discussion with physician, 11-20 minutes | 24 | $943 | $35 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 12 | $874 | $58 |
2020: 6 services
| Return visit (30+ min) | 132 | $11,051 | $54 |
| Telephone medical discussion with physician, 11-20 minutes | 52 | $2,241 | $37 |
| Telephone medical discussion with physician, 21-30 minutes | 20 | $1,377 | $66 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 14 | $1,143 | $50 |
| Aspiration and/or injection of fluid from large joint | 13 | $634 | $35 |
| Telephone medical discussion with physician, 5-10 minutes | 20 | $310 | $15 |
2019: 7 services
| Return visit (30+ min) | 178 | $22,280 | $60 |
| New patient visit (45+ min) | 38 | $3,614 | $95 |
| Long return visit (40+ min) | 19 | $1,791 | $94 |
| Aspiration and/or injection of fluid from large joint | 19 | $1,661 | $50 |
| Short return visit (20+ min) | 23 | $843 | $30 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 12 | $816 | $54 |
| Complete ultrasound scan of joint | 13 | $403 | $29 |
2018: 4 services
| New patient visit (45+ min) | 34 | $2,672 | $79 |
| Return visit (30+ min) | 29 | $2,409 | $43 |
| Return visit (30+ min) | 28 | $1,919 | $66 |
| Short return visit (20+ min) | 19 | $751 | $34 |
2017: 1 service
| New patient visit (45+ min) | 15 | $1,480 | $99 |
Medicaid work
$5,708 in 2024
Medicaid paid $5,708 for 1,750 billed services this clinician did in 2024, up to 63 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 483 | $5,708 |
| Pain severity quantified; pain present (COA) (ONC) | 21 | $0 |
| Medication list documented in medical record (COA) | 332 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 298 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 248 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 35 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 298 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 35 | $0 |
| 2024 | 1,750 | 8 | 63 | $5,708 |
| 2023 | 653 | 6 | 68 | $3,339 |
| 2022 | 577 | 5 | 63 | $3,559 |
| 2021 | 773 | 10 | 65 | $4,994 |
| 2020 | 693 | 8 | 54 | $3,964 |
| 2019 | 1,272 | 10 | 80 | $5,894 |
| 2018 | 127 | 5 | 63 | $549 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 567 | $3,339 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 21 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 20 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 13 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 19 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 13 | $0 |
2022
| Return visit (30+ min) | 477 | $3,027 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 24 | $203 |
| Measurement of C-reactive protein | 28 | $158 |
| Creatinine; blood | 33 | $112 |
| Short return visit (20+ min) | 15 | $59 |
2021
| Return visit (30+ min) | 385 | $2,610 |
| Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension | 12 | $614 |
| Short return visit (20+ min) | 91 | $358 |
| Measurement of C-reactive protein | 57 | $328 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 38 | $326 |
| Creatinine; blood | 67 | $241 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 18 | $238 |
| Sedimentation rate, erythrocyte; non-automated | 44 | $173 |
| Transferase; aspartate amino (AST) (SGOT) | 28 | $53 |
| Transferase; alanine amino (ALT) (SGPT) | 33 | $52 |
2020
| Return visit (30+ min) | 424 | $2,461 |
| New patient visit (30+ min) | 32 | $568 |
| Measurement of C-reactive protein | 51 | $299 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 24 | $212 |
| Creatinine; blood | 43 | $174 |
| Sedimentation rate, erythrocyte; non-automated | 38 | $153 |
| Transferase; aspartate amino (AST) (SGOT) | 52 | $56 |
| Transferase; alanine amino (ALT) (SGPT) | 29 | $41 |
2019
| Return visit (30+ min) | 792 | $3,335 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 79 | $679 |
| Measurement of C-reactive protein | 76 | $434 |
| New patient visit (45+ min) | 28 | $417 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 28 | $352 |
| Sedimentation rate, erythrocyte; non-automated | 75 | $293 |
| Creatinine; blood | 81 | $251 |
| Short return visit (20+ min) | 17 | $62 |
| Transferase; alanine amino (ALT) (SGPT) | 64 | $54 |
| Transferase; aspartate amino (AST) (SGOT) | 32 | $17 |
2018
| Return visit (30+ min) | 64 | $178 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 19 | $168 |
| Measurement of C-reactive protein | 13 | $76 |
| Creatinine; blood | 18 | $75 |
| Sedimentation rate, erythrocyte; non-automated | 13 | $52 |
Drugs they prescribed that Part D paid
$1,623,131
Pharmacies billed $1,623,131 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 5% of their Part D prescriptions (37 of 738) in 2024. Above the middle of the specialty; the typical rheumatology clinician is at 3%.
468 generic and 270 brand-name prescriptions · $1,623,131 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Enbrel Sureclick | 38 | $280,110 | $7,371 |
| Xeljanz | 37 | $214,859 | $5,807 |
| Cosentyx Sensoready (2 Pens) | 31 | $206,097 | $6,648 |
| Humira | 14 | $110,344 | $7,882 |
| Benlysta | 24 | $106,383 | $4,433 |
See all 19 drugs
| Enbrel Sureclick | 38 | $280,110 | $7,371 |
| Xeljanz | 37 | $214,859 | $5,807 |
| Cosentyx Sensoready (2 Pens) | 31 | $206,097 | $6,648 |
| Humira | 14 | $110,344 | $7,882 |
| Benlysta | 24 | $106,383 | $4,433 |
| Rinvoq | 17 | $102,726 | $6,043 |
| Humira(Cf) | 13 | $85,878 | $6,606 |
| Taltz | 14 | $79,449 | $5,675 |
| Humira | 11 | $71,375 | $6,489 |
| Mycophenolate Mofetil | 22 | $2,505 | $114 |
| Methotrexate | 70 | $2,094 | $30 |
| Hydroxychloroquine Sulfate | 42 | $1,302 | $31 |
| Diclofenac | 36 | $1,218 | $34 |
| Gabapentin | 24 | $468 | $20 |
| Prednisone | 62 | $441 | $7 |
| Hydrocodone-Acetaminophen | 30 | $419 | $14 |
| Omeprazole | 23 | $288 | $13 |
| Allopurinol | 30 | $257 | $9 |
| Celecoxib | 11 | $172 | $16 |
Year by year
| 2024 | 738 | 149 | 5% (37) | 37% | $1,623,131 |
| 2023 | 671 | 138 | 4% (26) | 35% | $1,387,259 |
| 2022 | 1,150 | 181 | 5% (55) | 39% | $2,308,754 |
| 2021 | 1,042 | 208 | 5% (47) | 35% | $1,780,679 |
| 2020 | 1,564 | 213 | 6% (100) | 32% | $2,226,536 |
| 2019 | 1,499 | 250 | 7% (105) | 34% | $2,096,163 |
| 2018 | 312 | 81 | None | 24% | $82,066 |
| 2017 | 23 | None | 0% (0) | None | $825 |
| 2016 | 19 | None | 0% (0) | None | $1,054 |
| 2015 | 180 | 32 | None | 25% | $10,117 |
| 2014 | 162 | 32 | None | None | $10,741 |
| 2013 | 201 | 39 | 0% (0) | None | $11,148 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 24 drugs
| Xeljanz | 40 | $277,630 | $6,941 |
| Enbrel Sureclick | 37 | $270,259 | $7,304 |
| Humira | 17 | $138,565 | $8,151 |
| Benlysta | 21 | $104,350 | $4,969 |
| Cosentyx Sensoready (2 Pens) | 12 | $89,740 | $7,478 |
| Humira(Cf) | 13 | $85,966 | $6,613 |
| Humira | 12 | $83,873 | $6,989 |
| Otrexup | 18 | $14,302 | $795 |
| Rasuvo | 13 | $7,615 | $586 |
| Mitigare | 11 | $4,359 | $396 |
| Hydroxychloroquine Sulfate | 45 | $2,667 | $59 |
| Methotrexate | 40 | $2,660 | $66 |
| Febuxostat | 11 | $2,474 | $225 |
| Mycophenolate Mofetil | 28 | $2,375 | $85 |
| Diclofenac | 53 | $2,313 | $44 |
| Leflunomide | 15 | $1,241 | $83 |
| Prednisone | 65 | $937 | $14 |
| Hydrocodone-Acetaminophen | 26 | $634 | $24 |
| Amlodipine Besylate | 14 | $581 | $42 |
| Gabapentin | 14 | $518 | $37 |
| Omeprazole | 23 | $383 | $17 |
| Allopurinol | 22 | $372 | $17 |
| Alendronate | 12 | $302 | $25 |
| Baclofen | 11 | $77 | $7 |
2022: 28 drugs
| Enbrel Sureclick | 82 | $478,069 | $5,830 |
| Humira | 63 | $410,576 | $6,517 |
| Xeljanz | 73 | $399,408 | $5,471 |
| Enbrel | 26 | $174,613 | $6,716 |
| Humira | 28 | $159,648 | $5,702 |
| Benlysta | 30 | $131,600 | $4,387 |
| Orencia Clickject | 20 | $99,534 | $4,977 |
| Humira(Cf) | 11 | $68,419 | $6,220 |
| Rinvoq | 12 | $65,696 | $5,475 |
| Actemra Actpen | 16 | $56,778 | $3,549 |
| Otrexup | 14 | $10,325 | $738 |
| Febuxostat | 27 | $9,060 | $336 |
| Rasuvo | 16 | $8,180 | $511 |
| Methotrexate | 92 | $7,108 | $77 |
| Mycophenolate Mofetil | 24 | $5,279 | $220 |
| Hydroxychloroquine Sulfate | 63 | $3,535 | $56 |
| Leflunomide | 16 | $1,843 | $115 |
| Diclofenac | 46 | $1,755 | $38 |
| Prednisone | 116 | $1,661 | $14 |
| Gabapentin | 25 | $1,540 | $62 |
| Azathioprine | 13 | $1,264 | $97 |
| Allopurinol | 50 | $1,025 | $20 |
| Hydrocodone-Acetaminophen | 39 | $873 | $22 |
| Omeprazole | 26 | $437 | $17 |
| Amlodipine Besylate | 24 | $343 | $14 |
| Tramadol | 14 | $316 | $23 |
| Alendronate | 15 | $250 | $17 |
| Ibuprofen | 14 | $145 | $10 |
2021: 26 drugs
| Humira | 66 | $387,497 | $5,871 |
| Enbrel Sureclick | 58 | $327,416 | $5,645 |
| Xeljanz | 51 | $266,932 | $5,234 |
| Humira | 29 | $163,204 | $5,628 |
| Enbrel | 25 | $148,269 | $5,931 |
| Humira(Cf) | 15 | $86,918 | $5,795 |
| Orencia | 15 | $75,704 | $5,047 |
| Actemra Actpen | 14 | $51,988 | $3,713 |
| Benlysta | 13 | $51,434 | $3,956 |
| Otrexup | 11 | $6,734 | $612 |
| Mitigare | 13 | $5,096 | $392 |
| Methotrexate | 82 | $4,751 | $58 |
| Febuxostat | 14 | $4,536 | $324 |
| Hydroxychloroquine Sulfate | 76 | $3,950 | $52 |
| Leflunomide | 26 | $3,234 | $124 |
| Azathioprine | 22 | $2,270 | $103 |
| Prednisone | 152 | $1,814 | $12 |
| Hydrocodone-Acetaminophen | 37 | $1,148 | $31 |
| Diclofenac | 21 | $846 | $40 |
| Allopurinol | 37 | $618 | $17 |
| Gabapentin | 15 | $580 | $39 |
| Ibuprofen | 27 | $347 | $13 |
| Omeprazole | 18 | $304 | $17 |
| Alendronate | 20 | $280 | $14 |
| Amlodipine Besylate | 14 | $142 | $10 |
| Meloxicam | 14 | $128 | $9 |
2020: 29 drugs
| Xeljanz | 99 | $504,330 | $5,094 |
| Enbrel Sureclick | 75 | $378,665 | $5,049 |
| Humira | 58 | $352,118 | $6,071 |
| Humira | 43 | $227,501 | $5,291 |
| Enbrel | 35 | $201,765 | $5,765 |
| Orencia | 25 | $116,886 | $4,675 |
| Orencia Clickject | 22 | $105,762 | $4,807 |
| Actemra | 16 | $64,918 | $4,057 |
| Humira(Cf) | 11 | $59,348 | $5,395 |
| Hydroxychloroquine Sulfate | 184 | $14,688 | $80 |
| Febuxostat | 27 | $10,011 | $371 |
| Methotrexate | 127 | $8,923 | $70 |
| Leflunomide | 39 | $6,637 | $170 |
| Colcrys | 11 | $3,972 | $361 |
| Azathioprine | 39 | $3,253 | $83 |
| Prednisone | 226 | $2,898 | $13 |
| Colchicine | 18 | $2,790 | $155 |
| Hydrocodone-Acetaminophen | 69 | $2,125 | $31 |
| Mycophenolate Mofetil | 11 | $1,448 | $132 |
| Diclofenac | 31 | $1,067 | $34 |
| Celecoxib | 17 | $690 | $41 |
| Allopurinol | 43 | $647 | $15 |
| Omeprazole | 32 | $529 | $17 |
| Gabapentin | 26 | $480 | $18 |
| Alendronate | 29 | $315 | $11 |
| Ibuprofen | 34 | $196 | $6 |
| Tramadol | 28 | $174 | $6 |
| Amlodipine Besylate | 15 | $111 | $7 |
| Meloxicam | 20 | $94 | $5 |
2019: 33 drugs
| Enbrel Sureclick | 83 | $430,279 | $5,184 |
| Humira | 68 | $397,010 | $5,838 |
| Xeljanz | 77 | $349,480 | $4,539 |
| Humira | 46 | $264,476 | $5,749 |
| Enbrel | 26 | $183,316 | $7,051 |
| Orencia Clickject | 18 | $84,597 | $4,700 |
| Benlysta | 19 | $70,880 | $3,731 |
| Actemra | 17 | $65,255 | $3,839 |
| Orencia | 13 | $57,213 | $4,401 |
| Hydroxychloroquine Sulfate | 111 | $17,046 | $154 |
| Uloric | 19 | $16,564 | $872 |
| Leflunomide | 49 | $9,456 | $193 |
| Methotrexate | 107 | $7,190 | $67 |
| Colchicine | 23 | $6,137 | $267 |
| Colcrys | 21 | $5,842 | $278 |
| Prednisone | 279 | $3,851 | $14 |
| Hydrocodone-Acetaminophen | 65 | $2,075 | $32 |
| Azathioprine | 25 | $1,396 | $56 |
| Diclofenac | 24 | $720 | $30 |
| Gabapentin | 20 | $581 | $29 |
| Celecoxib | 12 | $524 | $44 |
| Leucovorin | 15 | $500 | $33 |
| Omeprazole | 33 | $451 | $14 |
| Allopurinol | 22 | $426 | $19 |
| Alendronate | 36 | $397 | $11 |
| Baclofen | 22 | $268 | $12 |
| Ibuprofen | 20 | $218 | $11 |
| Oxycodone-Acetaminophen | 12 | $208 | $17 |
| Tramadol | 24 | $207 | $9 |
| Pantoprazole | 15 | $191 | $13 |
| Naproxen | 20 | $168 | $8 |
| Meloxicam | 16 | $76 | $5 |
| Cyclobenzaprine | 11 | $54 | $5 |
2018: 8 drugs
| Atovaquone | 11 | $11,539 | $1,049 |
| Colcrys | 13 | $2,892 | $222 |
| Methotrexate | 37 | $2,428 | $66 |
| Hydroxychloroquine Sulfate | 20 | $2,343 | $117 |
| Leflunomide | 15 | $1,837 | $122 |
| Prednisone | 122 | $1,067 | $9 |
| Sulfasalazine Dr | 13 | $490 | $38 |
| Allopurinol | 13 | $195 | $15 |
2017: 1 drug
| Prednisone | 12 | $71 | $6 |
2015: 2 drugs
| Advair Diskus | 14 | $4,750 | $339 |
| Lisinopril | 16 | $49 | $3 |
2014: 1 drug
| Simvastatin | 15 | $99 | $7 |
2013: 2 drugs
| Potassium Chloride | 16 | $467 | $29 |
| Famotidine | 13 | $87 | $7 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1518221928
- Licence
- WI 61260-20
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RR0500X (207RR0500X); Student in a training program (390200000X)
- Mailing address
- 600 Highland Ave, Madison, WI, 53792
- NPI first listed
- 2012-06-29
- NPI last updated
- 2017-01-06
This is when the NPI record was last certified, not a medical board exam.